| INF |
Table INF-0. Bibliographic references
|
table |
| INF |
Table INF-1. Prevalence of HIV infection among injecting drug users in the EU, 2006 or most recent year available — Summary table by country
|
table |
| INF |
Table INF-2. Prevalence of HCV antibody among injecting drug users in the EU, 2006 or most recent year available — Summary table by country
|
table |
| INF |
Table INF-3. Prevalence of markers for HBV infection among injecting drug users in the EU, 2006 or most recent year available — Summary table by country
|
table |
| INF |
Table INF-18. Trends in HIV prevalence among injecting drug users estimated from national and sub-national samples, 2001 to 2006, samples with average prevalence above 5 %
|
table |
| INF |
Table INF-19. Trends in HCV antibody prevalence in national and subnational samples of injecting drug users 2001 to 2006, countries with average prevalence above 50 %.
|
table |
| INF |
Table INF-104. HIV infections newly diagnosed in injecting drug users, by year of report from 1992 to 2006, (a) cases per million population, (b) number of cases and (c) population sizes
|
table |
| INF |
Table INF-105. Notified cases of hepatitis C infection among injecting drug users in the EU: number of IDU cases and percentage of IDUs amongst all cases with known risk factor
|
table |
| INF |
Table INF-106. Notified cases of hepatitis B infection among injecting drug users in the EU: number of IDU cases and percentage of IDUs amongst all notified cases with known risk factor
|
table |
| INF |
Table INF-107. Incidence studies of hepatitis C virus infection among injecting drug users in the EU
|
table |
| INF |
Table INF-108. Prevalence of HIV infection (percentage) among injecting drug users, 1991 to 2007
|
table |
| INF |
Table INF-109. Prevalence of HIV infection (percentage) among injecting drug users under age 25, 1991 to 2007
|
table |
| INF |
Table INF-110. Prevalence of HIV infection (percentage) among new injecting drug users (injecting less than 2 years), 1991 to 2006
|
table |
| INF |
Table INF-111. Prevalence of hepatitis C infection (percentage) among injecting drug users, 1991 to 2007
|
table |
| INF |
Table INF-112. Prevalence of hepatitis C infection (percentage) among injecting drug users under age 25, 1991 to 2007
|
table |
| INF |
Table INF-113. Prevalence of hepatitis C infection (percentage) among new injecting drug users (injecting less than 2 years), 1991 to 2006
|
table |
| INF |
Table INF-114. Prevalence of current hepatitis B infection (percentage with HBsAg) among injecting drug users, 1991 to 2006
|
table |
| INF |
Table INF-115. Prevalence of antibodies against hepatitis B virus (percentage) among injecting drug users, 1991 to 2006
|
table |
| INF |
Table INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2006
Part (i) Prevalence of HIV infection (percentage) among injecting drug users in prison
|
table |
| INF |
Table INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2006
Part (ii) Prevalence of hepatitis C infection (percentage) among injecting drug users in prison
|
table |
| INF |
Table INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2006
Part (iii) Prevalence of current hepatitis B infection (percentage with HBsAg) among injecting drug users in prison
|
table |
| INF |
Table INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2006
Part (iv) Prevalence of antibodies against hepatitis B virus (percentage) among injecting drug users in prison
|
table |
